Main Content
What is a target product profile (TPP) and why should you have one for you CAR T-cell therapy? A guest blogger from @CCRM_au explains. https://www.signalsblog.ca/target-product-profile-starting-that-journey-of-a-thousand-miles-with-the-right-first-step/
We want safe and efficacious iPSC therapeutics that have clinical impact globally. Is Quality Testing consistent and indicative for your "clinical-grade" iPSCs? GAiT & @CiRA_F_J conduct iPSC Quality Assessment Rounds to assist efficient translation.
At day 2 of the iPSC Manufacturing Summit, GAiT is chairing this morning's session entitled "Developing iPSC Differentiation to Efficently Create the Desired Cell Type".
iPSC Manufacturing Summit 2022
Join us in Boston for the iPSC Manufacturing Summit, the only forum dedicated to optimizing the scalable manufacture...
www.ipsc-manufacturing-summit.com
GAiT is happy to chair this morning's session entitled "Equipping iPSC Expansion Practices to Cater for Scale-Up & Commercialization" at the iPSC Manufacturing Summit http://www.ipsc-manufacturing-summit.com
iPSC Quality Round Participants have received automated emails regarding manuscript submission this week. We would be grateful if you can respond to these. If you have already done so, thank you.
GAiT will speak at the iPSC Manufacturing Summit in Boston next week. Details at http://www.ipsc-manufacturing-summit.com
